Velvet Therapeutics

Private

Houston, TexasHealthcare & Life Scienceshttps://www.velvettherapeutics.com/

Last Round

VC Round

Sep 18, 2023

Total Funding Raised

$1.62M

Company Overview

Velvet Therapeutics is a biotechnology company developing gene therapies intended to treat rare cancers and autoimmune diseases using a proprietary non-viral, in vivo CAR platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vivo gene therapynon-viral gene therapyCAR therapiesgene delivery platformminicircle DNAmcDNAbiodegradable nanoparticlesoff-the-shelf therapyin vivo cell engineeringautoimmune disease therapysolid tumor therapynanoparticle deliveryimmune cell reprogrammingSystemic Lupus ErythematosusSLEB cell depletion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Velvet Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Velvet Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Velvet Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Sep 18, 2023
Debt	Aug 28, 2023
Seed	Jan 11, 2021

View all Funding Rounds

Velvet Therapeutics Investors

Notable investors and investment history

Velvet Therapeutics investors
Investor	Rounds
BCM Ventures	VC Round, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 18, 2023
Raised $2M from BCM Ventures.
Aug 28, 2023
$500K debt round completed.

View all signals

Velvet Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Velvet Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Velvet Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas

Year FoundedN/A

Last FundingSep 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.